PRIMENA NOVIH TERAPIJSKIH STRATEGIJA U LEČEWU SEPSE I SEPTIČNOG ŠOKA U JEDINICI INTENZIVNOG LEČEWA KLINIČKOG CENTRA U KRAGUJEVCU
|
|
- Kelly Bond
- 5 years ago
- Views:
Transcription
1 RADOVI BIBLID: , 136(2008) 5-6, p DOI: /SARH J UDC: (497.11) PRIMENA NOVIH TERAPIJSKIH STRATEGIJA U LEČEWU SEPSE I SEPTIČNOG ŠOKA U JEDINICI INTENZIVNOG LEČEWA KLINIČKOG CENTRA U KRAGUJEVCU Jasna JEVĐIĆ 1, Maja ŠURBATOVIĆ 2, Svetlana DRAKULIĆ-MILETIĆ 3, Vladimir VUKIĆEVIĆ 1 1 Centar za anesteziju i reanimaciju, Klinički centar Kragujevac, Kragujevac; 2 Klinika za anesteziologiju i intenzivnu terapiju, Vojnomedicinska akademija, Beograd; 3 Klinika za neurologiju, Klinički centar Kragujevac, Kragujevac KRATAK SADRŽAJ Uvod Upr kos raz vo ju me di cin ske na u ke, sto pa smrt no sti od te ške sep se i sep tič nog šo ka i da qe je vi so ka (30-50%). No ve terapijske strategije za lečewe teške sep se i sep tič nog šo ka, ko je ob u hva ta ju ra nu ciq nu te ra pi ju, pra vo vre m e n u p r im en u a d ek v a tn e a nt im ik r o bn e t er ap ij e, ko n t r o l u i z v o r a i n f e k c i j e, p r i m e n u ko r t i ko s t e r o i d n i h p r e p a r a ta, va zopresornih i inotropnih lekova, odnosno re kom bi no va nog pro te i na C, strikt nu kon tro lu gli ke mi je i me ha nič ku ventilaciju malim respiratornim volume nom, mo gu po boq ša ti is hod le če wa bo le sni ka. Sve o bu hvat na i br za pri me na pro to ko la ta ko đe uti če na is hod le če wa. Ciq rada Ciq ra da je bio da se utvr di da li su no ve te ra pij ske smer ni ce in te gri sa ne u ru tin sku kli nič ku praksu u na šoj ze mqi. Metod rada V r š e n a j e r e t r o sp e k t i v n a a n a l i z a k l i n ič k i h p o d a t a k a o sob a koj e s u z b o g teš ke se pse i l i se pt ičn o g š ok a l e č e n i u J ed in ic i i nt e nz i vn o g l e č ew a K l i n ič ko g c e n t r a u K r a g u j e v c u t o ko m d e se t o m e seč n o g p e r i o d a. U r a d u j e p r i mewen deskrip tiv ni epi de mi o lo ški me tod. Pro ce wi va ni su : ka te te ri za ci ja cen tral ne ve ne, cen tral ni ven ski pri ti sak, primena antibiotske terapije, na dokna da cir ku la tor nog vo lu me na teč no sti ma, me ha nič ka ven ti la ci ja, tran sfu z i j a k rv i, p r of il a ks a s t r e s- ulk us a, p r of il a k s a d u b o ke v e n s ke t r o m b o z e, ko n t r o l a gl i ke m i j e. Rezultati To ko m p o s m a t r a n o g p e r i o d a l e č e n o j e 27 b o l e sn i k a (16 m u š ko g p o l a) p r o seč n e s t a r o s t i o d 49,9 ±16,7 go d i n a (ras pon: go di na); sto pa mor ta li te ta bi la je 48,1%. Svi is pi ta nici su na početku lečewa primili antibiotske le ko v e š ir oko g s p e kt r a d e js t v a. Uz or a k k rv i z a hem o k ul t u ru u z e t j e o d 2 3 b o l e s n i k a; 16 b o l e s n i k a j e p r i m a l o a d e k v a t n u a n t i m i k r o bn u t er ap ij u ; ko d 20 b ol es n ik a s u b el e ž e n e v r e d n o s t i c e n t r a l n o g v e n sko g p r i t i sk a, ko j i j e u p r o se k u b i o 8,47±5,6 mm Hg (-2-20); ko d d ev e t b ol es n ik a j e p r i m e w e n a b r z a n a d o k n a d a c i r k u l a t o r n o g v o l u m e n a t eč n o s t i m a; 18 i s p i t a n i k a u se pt ičn o m š ok u l eč en o j e v az oa kt i v n i m l e ko v i m a, o d č e g a o s m o r o wi h ko r t i ko s t e r o i d n i m p r e p a r a t i m a, dok je 16 bo le sni ka pri mi lo tran sfu zi ju kr vi. Kod svih is pi ta ni ka primewena je pro fi lak sa stres-ul ku sa, a kod 10 b ol es n ik a p r of il a ks a d ub oke v e nske t r o mb oz e. P r o seč n a v r e d n o s t j u t a r w e gl i ke m i j e b i l a j e 9,11± 5, 03 mmol/l (ras pon: 3,7-22,0 mmol/l). Na me ha nič koj ven ti la ci ji bi lo je 17 bo le sni ka. Ni vo lak ta ta u kr vi ni je od re đi van. Zakqučak V o d ič i (s m e rn ic e) z a l eč ew e t eš ke se p se i se p t ič n o g š o k a z a s n o v a n i n a d o k a z i m a se u J e d i n i c i i n t e n ziv nog lečewa Kliničkog centra u Kragujevcu ne pri me wu ju na sve o bu hva tan i si ste ma ti čan na čin. Insti tu ci o nal no pri hva ta we ovih pro to ko la i edu ka ci ja le ka ra kli ni ča ra će si gur no po boq ša ti pre ži vqa va we oso ba obo lelih od te ške sep se. Kqučne reči: sepsa; protokol; terapija UVOD Uprkos razvoju medicinske nauke, stopa smrtnosti od teške sepse i septičnog šoka i daqe je visoka (30-50%). Prema podacima Centara za kontrolu i prevenciju bolesti Sjediwenih Američkih Država (US Cen ters for Di se a se Con trol and Pre ven tion CDC), sepsa je jedan od deset vodećih uzroka smrti u SAD i od we umire približno isto qudi kao i od infarkta miokarda. Međunarodno organizovane kampawe koje su ukqučivale stručwake različitih profila izraz su napora da se stopa smrtnosti od sepse smawi. Rezultat rada 11 međunarodnih profesionalnih organizacija, predvođenih Evropskim društvom za intenzivnu terapiju (Euro pean Inten si ve Care So ci ety), Društvom za intenzivnu medicinu (So ciet y of Cr i ti cal C a re Me di c i ne) i Međunarodnim forumom za sepsu (Inter na ti o nal Sep sis Fo rum), jesu smernice, odnosno protokoli lečewa sepse koji su zasnovani prvenstveno na rezultatima randomiziranih studija koje su obuhvatile veliki broj ispitanika. Uticaj primene protokola na ishod lečewa osoba obolelih od sepse se formalno prati, a protokoli se godišwe po potrebi i češće prilagođavaju novostečenim saznawima i dokazima. Istraživawa Riversa (Ri vers) i saradnika [1] su pokazala da se ranom usmerenom terapijom smrtnost bolesnika od sepse može smawiti i za 16%. Beth Israel D e a co ness Me dical C e nte r u Bostonu uvrstio je u svoj svakodnevni rad rani agresivni terapijski protokol lečewa sepse koji se zasniva na: ranoj ciqnoj terapiji, pravovremenoj primeni antibiotskih lekova, aktiviranog proteina C, kortikosteroidnih preparata i insulina, te na protektivnoj ventilaciji pluća. Ovaj protokol je nazvan simbolično MUST (Mul ti ple Ur gent Sep sis The ra pi es) protokol, što nagla 248
2 šava neophodnost wegove primene kod osoba obolelih od sepse. Smernice (vodiči) za lečewe teške sepse jasno naglašavaju značaj ranog prepoznavawa sepse i pravovremene primene početne terapije (u prvih šest sati od nastanka simptoma) u zaustavqawu kaskade sepse. Lečewe neodložno treba početi kod bolesnika kod kojih se sumwa na infekciju, kod kojih su zadovoqena bar dva kriterijuma za sindrom sistemskog inflamatornog odgovora (SIRS), odnosno kod bolesnika kod kojih je utvrđena hipoperfuzija tkiva. Smatra se da se hipoperfuzija tkiva javqa kada je sistolni krvni pritisak niži od 90 mm Hg, kada je nivo laktata u serumu veći od 4 mmol/l, te kod hipotenzije. Početnom terapijom, prema objavqenim i prihvaćenim protokolima [2], treba da se postigne sledeće: centralni venski pritisak (CVP) 8-12 mm Hg, sredwi arterijski pritisak (MAP) veći od 65 mm Hg, diureza veća od 0,5 ml/kg/h i zasićenost mešane venske krvi kiseonikom veća od 70%. Parametri rane ciqne terapije i objašwewa: 1. Rana agresivna nadoknada cirkulatornog volumena tečnostima (kristaloidi ili koloidi) uz striktan nadzor odgovora bolesnika na wu; 2. Kada adekvatna nadoknada cirkulatornog volumena t e č no s t i ma ne dov e de do pov e ć a w a k rvnog pritiska i adekvatne perfuzije tkiva, primewuj u s e v a z op r e s orna t e r a p i ja (nor a d r ena l i n i l i dopamin) i inotropna terapija (dobutamin); 3. Zasićenost mešane venske krvi kiseonikom je indikator balansa dostave kiseonika tkivima i wegove potrošwe u wima, te kada je mawa od 70% i posle normalizovawa CVP i MAP, a nivo hematokrita mawi od 30 %, treba primeniti transfuziju krvi; 4. Primenu intravenske antibiotske terapije treba početi odmah, tokom prvog sata od prepoznavawa simptoma sepse, posle uzimawa uzoraka krvi za hemokulturu iz periferne vene; dejstvo antibiotske terapije treba proceniti na osnovu mikrobioloških i kliničkih podataka posle časa i primeniti antibiotske lekove prema antibiogramu; 5. Izvor infekcije (apsces, inficirano nekrotično tkivo, gastrointestinalne perforacije i dr.) treba što pre odstraniti najmawe agresivnim hirurškim metodom posle adekvatnog zbriwavawa bolesnika; 6. Primena intravenskih kortikosteroida se preporu č u je kod boles nika u sep t i čnom šok u koji ma j e i por e d a dek v at ne na dok na de c i rk u l at ornog volumena tečnostima potrebna vazopresorna terapija, odnosno kod bolesnika koji imaju relativnu adrenalnu insuficijenciju (posle primene 250 μg a d renokor t ikot rop nog hormona ACTH povećawe nivoa kortizola je mawe od 9 μg/dl); 7. Rekombinantni humani aktivirani protein C (rhapc) primeniti kod bolesnika sa sindromom multiple organske disfunkcije (MODS) izazvanog sepsom ili kod osoba u septičnom šoku, kada je rizik od smrtnog ishoda veliki i kada ne postoji apsolutna kontraindikacija zbog rizika od krvarewa; 8. Kod bolesnika u septičnom šoku i s akutnom slabošću disajnih organa preporučuje se protekt i vna ven t i la c i ja p l uća ma l i m res p i ratorn i m volumenom (6 ml/kg idealne telesne mase), pri čem u p ri t is a k en d i ns p i rat ornog p lat oa t r e ba da bude mawi od 30 cm H 2 O, uz primenu najmaweg pozitivnog pritiska na kraju izdisaja (PE E P), kojim bi se postigla zadovoqavajuća oksigenacija ; 9. Koristiti protokole sedacije za bolesnike na mehaničkoj ventilaciji; 10. Preporučuje se česta kontrola glikemije (6-9 mmol/l) kontinuiranim infuzijama insulina i gl ikoze; 11. Adekvatna ishrana bolesnika je takođe veoma važna, a preporučuje se enteralni put hrawewa; 12. Kod akutne insuficijencije bubrega primewuje se hemodijaliza; 13. Bikarbonati se u lečewu laktične acidoze primewuju tek kada je vrednost ph mawa od 7,15; 14. Profilaksa duboke venske tromboze (male doze heparina ili niskomolekularni heparin); 15. Profilaksa stres-ulkusa (inhibitori vodonikovih receptora). Ciq svih međunarodnih, multidisciplinarnih kampawa jeste da se definišu protokoli zasnovani na dokazima čijom će se primenom u praksi unaprediti lečewe osoba obolelih od teške sepse i smawiti smrtnost za oko 25%. Potrebno je posmatrati i dokumentovati primenu preporučenih vodiča u kliničkoj praksi, kako bi se utvrdili efekti wegove primene na ishod lečewa i predložile eventualne izmene koje bi dovele do poboqšawa. CIQ RADA Ciq rada je bio da se proceni da li se i u kojoj meri u Kliničkom centru u Kragujevcu primewuju nove terapijske strategije u lečewu teške sepse, analiziraju problemi i sagledaju mogućnosti daqeg unapređewa ovih protokola lečewa radi smawewa smrtnosti osoba obolelih od teške sepse. METOD RADA Istraživawe je izvedeno godine u Jedinici intenzivnog lečewa Kliničkog centra u Kragujevcu, gde je lečeno bolesnika (5.594 bolesnička dana). Retrospektivnom analizom istorija bolesti osoba lečenih u ovoj jedinici od januara do novembra godine, u studiju su ukqučeni bolesnici koji su zadovoqavali kriterijume za tešku sep 249
3 su (sepsa sa disfunkcijom jednog ili više organa) ili septični šok (sepsa s hipotenzijom uprkos adekvatnoj nadoknadi cirkulatornog volumena). Primena novih terapijskih preporuka je procewivana na osnovu: uzoraka krvi za hemokulturu, rane primene antibiotskih lekova, kateterizacije centralnih vena i merewa CVP, rane nadoknade tečnosti, primene vazoaktivnih lekova, kontrole glikemije, primene kortikosteroida, krvi, tromboprofilakse, profilakse stres-ulkusa, mehaničke ventilacije. Za statističku obradu podataka korišćen je programski paket SPSS REZULTATI U studiju je ukqučeno 27 bolesnika (16 muškaraca) prosečne starosti od 49,9±16,7 godina (raspon: godina). Uzrok sepse je kod osam bolesnika bio akutni pankreatitis, kod devet bolesnika infekcija u abdomenu, a kod po pet ispitanika teška trauma različite etiologije, odnosno pneumonija. Hirurški je lečen 21 bolesnik (77,8%). Posle 30 dana lečewa preživelo je 14 ispitanika, a stopa smrtnosti tokom posmatranog desetomesečnog perioda bila je 48,1% (Tabela 1). Tokom prvog sata od prijema u Jedinicu intenzivnog lečewa svi bolesnici su primili najmawe jedan antibiotik širokog spektra dejstva iz grupe cefalosporina druge ili treće generacije, aminoglikozida ili hinolona u prepisanoj dozi. Bolesnici kod kojih je dijagnostikovan akutni pankreatitis primili su antibiotik iz grupe karbapenema. Od 23 ispitanika je odmah po prijemu, a pre primene antibiotskog leka, uzet uzorak krvi za hemokulturu. Kod 16 ispitanika inicijalno primeweni antibiotici bili su odgovarajući prema antibiogramu. Kod ostalih bolesnika izolovane bakterije su pokazale rezistentnost na primewene antibiotske lekove, te je bilo neophodno promeniti antibiotsku terapiju i TABELA 1. Osnovne odlike bolesnika. TABLE 1. Basic characteristics of patients. Parametar Parameter Ukupan broj bolesnika Total number of patients Uzrast (godine) Age (years) Pol (muški/ženski) Gender (male/female) Akutni pankreatitis Acute pancreatitis Intraabdomenska infekcija Intra-abdominal infection Trauma Trauma Pneumonija Pneumonia Smrtnost Mortality Vrednost Result (18-77) 16/11 8 (29.7%) 9 (33.3%) 5 (18.5%) 5 (18.5%) 13/14 (48.1%) primeniti piperacilin, meropenem, imipenem, teikoplanin, netilmicin i vankomicin. Tokom prvih šest sati po prijemu kod 20 bolesnika je postavqen centralni venski kateter, a prosečna vrednost CVP posle šest sati bila je 8,47±5,6 mm Hg (-2-20). Kod devet bolesnika je vršena agresivna nadoknada tečnosti (najmawe 20 ml/kg kristaloida u prvom satu od prijema). Kod 18 bolesnika u septičnom šoku primeweni su vazoaktivni lekovi (dopamin u dozi 2-5 μg/kg), a kod osam bolesnika kortikosteroidi. Transfuziju koncentrovanih eritrocita primilo je 16 bolesnika. Lekove za profilaksu stres-ulkusa dobijali su svi ispitanici, a za profilaksu tromboze dubokih vena samo deset bolesnika. Prosečna jutarwa vrednost glikemije prvog dana po prijemu bila je 9,11±5,03 mmol/l (raspon: 3,7-22,0 mmol/l). Na različitim tipovima mehaničke ventilacije bilo je 17 bolesnika (Tabela 2). DISKUSIJA Analizom primene novih preporučenih postupaka i mera za lečewe teške sepse i septičnog šoka u rutinskoj praksi Jedinice za intenzivno lečewe Kliničkog centra u Kragujevcu zapaženo je da se oni ne primewuju adekvatno, iako su lekari upoznati s ovim protokolima na stručnim sastancima kroz predavawa koja su se odnosila na ovu aktuelnu temu. Nivo laktata u serumu, kao dobar prognostički pokazateq ishoda sepse [3], nije određivan, iako tehničke mogućnosti za to postoje. Odmah po prijemu svi bolesnici su primili antibiotsku terapiju. Kriterijume za izbor antibiotskih lekova treba preispi TABELA 2. Primena pojedinih elemenata rane ciqne terapije. TABLE 2. The performed individual elements of early goal-directed therapy. Terapijsko-dijagnostička mera Therapy/diagnostic measure Adekvatna antimikrobna terapija Adequate antimicrobial therapy Hemokultura Blood culture Nadzor centralnog venskog pritiska Central venous pressure monitoring Adekvatna terapija tečnostima Adequate fluid therapy Vazoaktivni lekovi Vasoactive drugs Kortikosteroidi Corticosteroids Transfuzija eritrocita Red blood cell transfusion Profilaksa stres-ulkusa Stress ulcer prophylaxis Profilaksa duboke venske tromboze Deep vein thrombosis prophylaxis Mehanička ventilacija Mechanical ventilation Nivo laktata u krvi Blood lactate level Broj bolesnika Number of patients 16 (59.3%) 23 (85.2%) 20 (74.1%) 9 (33.3%) 18 (66.7%) 8 (29.6%) 16 (59.3%) 27 (100%) 10 (37%) 17 (63%) 0 (0%) 250
4 tati zato što se ni kod jednog ispitanika nije primewivao deeskalacioni princip (početna primena najjačih antibiotika širokog spektra dejstva), koji se pokazao kao najdelotvorniji. Uzorci krvi za hemokulturu su uzeti od 23 bolesnika. Kako mnoga eksperimentalna i klinička ispitivawa jasno dokazuju neophodnost što ranije primene adekvatne antibiotske terapije [4, 5], potrebno je dizajnirati sopstvene protokole postupawa kod bolesnika kod kojih se sumwa na sepsu, a uzorke krvi za hemokulturu i određivawe nivoa laktata uzimati neposredno po prijemu u bolnicu. Centralni venski kateter je postavqen kod 20 bolesnika radi nadgledawa nadoknade tečnosti, a agresivna nadoknada cirkulatornog volumena tečnostima (kristaloidima ili koloidima) vršena je kod samo devet bolesnika, što bi trebalo poboqšati, jer je ona jedna od osnovnih preporuka prihvaćenih vodiča u lečewu teške sepse, budući da vrednosti CVP i MAP direktno utiču na smrtnost bolesnika u septičnom šoku [6, 7]. Nekada se smatralo da je sepsa bolest mikrocirkulacije, odnosno narušene autoregulacije lokalnog krvnog protoka [8]. Novija istraživawa su, međutim, pokazala da se ona javqa samo u prvih šest sati. U principu, kada se isporuka kiseonika smawi zbog niskog parcijalnog pritiska kiseonika (po 2 ) u arterijskoj krvi, anemije, odnosno hipoperfuzije, ćelije vrše ekstrakciju proporcionalno većeg dela dostupnog kiseonika kako bi očuvale aerobnu sintezu adenozintrifosfata (ATP), usled čega se po 2 u tkivima smawuje. Međutim, kod sepse sinteza ATP je smawena zbog unutrašweg poremećaja ćelijske respiracije (citopatska hipoksija), ćelije ekstrahuju mawe kiseonika od onog koji je dostupan, što dovodi do povećawa vrednosti po 2 u tkivima. Citopatska hipoksija nije zastupqena neposredno nakon početka sepse, ali se razvija u prvih nekoliko sati. Ovim se mogu objasniti pozitivni rezultati dobijeni primenom rane usmerene hemodinamske terapije, kao i nepovoqni rezultati kada se ona primewuje kod bolesnika u kasnijoj fazi. Vazopresorni i inotropni lekovi povećavaju minutni volumen srca i sistemski protok krvi, ali ne mewaju značajno protok u mikrocirkulaciji [9, 10], što objašwava nalaze nekih kliničkih studija koji kažu da primena ovih lekova ne smawuje smrtnost bolesnika [11]. Vazopresorna terapija je primewena kod 18 bolesnika u septičnom šoku. Adrenalna insuficijencija je čest nalaz kod ovih bolesnika, ali određivawe nivoa kortizola u serumu i stimulacioni kortikotropinski test nisu rađeni kod ispitanika našeg istraživawa. Kortikosteroidna terapija kod bolesnika s hipotenzijom i posle adekvatne nadoknade volumena primewena je kod samo osam bolesnika, iako podaci iz literature govore o nesumwivoj opravdanosti primene malih doza kortikosteroida tokom sedam dana [12, 13]. Prosečna vrednost glikemije kod ispitivanih bolesnika bila je 9,11±5,03 mmol/l. Prema preporukama usvojenih kliničkih vodiča, neophodno je postići boqu kontrolu glikemije i održavati je u opsegu 6-9 mmol/l kontinuiranim infuzijama glikoze i insulina, uz kontrolu na svaki sat, jer ova striktna kontrola glikemije poboqšava ishod lečewa bolesnika. Profilaksa stres-ulkusa je rutinski primewivana kod svih bolesnika, ali je profilaksa tromboze dubokih vena primewena kod deset bolesnika, te dodatno treba naglasiti wen značaj i uvrstiti je u interne protokole. Rekombinantni humani aktivirani protein C (rhapc) nije prepisivan za lečewe, ali nije bio ni dostupan lekarima. Istraživawa su pokazala neke wegove korisne efekte u lečewu septičnog šoka zbog wegovih antiinflamatornih i hemodinamskih svojstava, budući da smawuje stvarawe azot-oksida (NO) i poboqšava vaskularni tonus [14]. Da bi se smrtnost bolesnika od teške sepse smawila, neophodno je preporučene dijagnostičke i terapijske postupke, kao i nadzor vitalnih funkcija bolesnika sprovesti sveobuhvatno i dosledno. Ishod lečewa je znatno boqi kada se svi elementi terapijskog protokola primene kao celina, nego kada se pojedinačno primewuju neki od wih. Preduslov za ovo je svakako edukacija medicinskog osobqa za rano i brzo prepoznavawe bolesnika na koje protokol treba primeniti, jer je vreme najvažniji faktor za uspeh lečewa. Potrebno je voditi evidenciju primewenih postupaka i mera, a potom proceniti rezultate i ishod lečewa bolesnika. ZAKQUČAK Uputstva međunarodnih multidisciplinarnih vodiča lečewa teške sepse i septičnog šoka se u Jedinici intenzivnog lečewa Kliničkog centra u Kragujevcu ne primewuju na sveobuhvatan i potpun način. Neophodno je napraviti praktičan plan uvođewa ovih smernica u rutinsku kliničku praksu, što bi nesumwivo dovelo do smawewa stope smrtnosti osoba obolelih od teške sepse i septičnog šoka. LITERATURA 1. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: Dellinger Ph, Carlet J, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: Shapiro N, Howell M, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005; 45: Kumar A, Haery C, Paladugu B, et al. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 2006; 193(2): Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient 251
5 outcomes in ICU setting. Chest 2000; 118: Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32(Suppl 11): Varpula M, Tallgren M, Saukkonen K, et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31(8): De Blasi RA, Palmisani S, Alampi D, et al. Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med 2005; 31(12): Hiltebrand LB, Krejci V, Sigurdsson GH. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 2004; 100(5): Krejci V, Hiltebrand LB, Sigurdsson GH. Effect of epinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 2006; [Epub ahead of print] 11. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34(3): Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34(1): Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288(7): Monnet X, Lamia B, Anguel N, et al. Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients. Intensive Care Med 2005; 31(11): NEW THERAPY STRATEGIES FOR TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK IN INTENSIVE CARE UNIT OF CLINICAL CENTRE IN KRAGUJEVAC Jasna JEVDJIĆ 1, Maja ŠURBATOVIĆ 2, Svetlana DRAKULIĆ-MILETIĆ 3, Vladimir VUKIĆEVIĆ 1 1 Centre for Anaesthesia and Resuscitation, Clinical Centre Kragujevac, Kragujevac; 2 Clinic of Anaesthesiology and Intensive Therapy, Military Medical Academy, Belgrade; 3 Clinic of Neurology, Clinical Centre Kragujevac, Kragujevac INTRODUCTION Despite numerous advances in medicine, the mortality rate of severe sepsis and septic shock remains high, 30-50%. New therapy strategies include: early goaldirected therapy, fluid replacement, early and appropriate antimicrobials, source of infection control, use of corticosteroids, vasopressors and inotropic therapy, use of recombinant activated protein C, tight glucose control, low-tidal-volume mechanical ventilation. They have been shown to improve the outcomes. The adequacy and speed of treatment influence the outcome, too. OBJECTIVE The objective was to evaluate if new therapy strategies had been integrated in our routine practice. METOD Patients with severe sepsis or septic shock, who were treated in the Intensive Care Unit (ICU) over a ten-month period, were analysed retrospectively. The descriptive epidemiological method was applied. Central venous catheterization, central venous pressure, antibiotics, fluid resuscitation, mechanical ventilation, vasopressors, corticosteroids, blood administration, deep vein thrombosis prophylaxis, stress ulcer prophylaxis, glucose control, were evaluated. RESULTS 27 patients were analysed. Patient characteristics were: age, 49.9 years (18-77) with 30-day in-hospital mortality rate of 48.1%. All patients received broad-spectrum antibiotics. Blood cultures were obtained in 85.2% patients. Adequate antimicrobial treatment was applied to 59.3% and 74.1% patients had central venous pressure monitoring. Average central venous pressure was 8.47±5.6 mm Hg (-2-20). Aggressive fluid therapy was given to 33.3% of the cases and 66.7% of the patients with septic shock received vasoactive drugs while 29.6% received corticosteroids. Red blood cell transfusions were applied in 59.3% of patients. All patients received stress ulcer prophylaxis, and 37% of them deep vein thrombosis prophylaxis. The average value of morning glucose was 9.11±5.03 mmol/l ( ). 63% of patients were mechanically ventilated. Blood lactate was not determined. CONCLUSION Evidence-based clinical guidelines for management of severe sepsis and septic shock have not been implemented in a widespread, systematic way in the ICU of the Clinical Centre, Kragujevac. Institutional acceptance of this protocol, and education of clinicians may improve survivability for patients with sepsis. Key words: sepsis; protocol; therapy Jasna JEVĐIĆ Centar za anesteziju i reanimaciju Klinički centar Kragujevac Zmaj Jovina 30, Kragujevac Tel.: ortzek@sbb.co.yu * Rukopis je dostavqen Uredništvu godine. 252
A Sound Track to Reading
A Sound Track to Reading Blending Flashcards Prepared by Donald L Potter June 1, 2018 Mr. Potter prepared these cards to be used with Sister Monica Foltzer s advanced intensive phonics program and reader,
More informationEvidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationObjectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy
Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of
More informationSepsis Update: Focus on Early Recognition and Intervention. Disclosures
Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will
More informationNew Strategies in the Management of Patients with Severe Sepsis
New Strategies in the Management of Patients with Severe Sepsis Michael Zgoda, MD, MBA President, Medical Staff Medical Director, ICU CMC-University, Charlotte, NC Factors of increases in the dx. of severe
More informationBC Sepsis Network Emergency Department Sepsis Guidelines
The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to
More informationSepsis is an important issue. Clinician s decision-making capability. Guideline recommendations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%
More informationANALIZA BOLNIČKE SMRTNOSTI OD AKUTNOG INFARKTA MIOKARDA S ELEVACIJOM ST SEGMENTA U KORONARNIM JEDINICAMA BEOGRADA
RADOVI BIBLID: 0354 2793, 136(2008) Suppl 2, p. 84-96 UDC: 616.127-005.8-073.7-02-036 ANALIZA BOLNIČKE SMRTNOSTI OD AKUTNOG INFARKTA MIOKARDA S ELEVACIJOM ST SEGMENTA U KORONARNIM JEDINICAMA BEOGRADA Zorana
More informationEFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
More informationVasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada
Vasopressors in Septic Shock Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada Echocardiogram: EF=25% 57 y.o. female, pneumonia, shock Echocardiogram: EF=25% 57 y.o.
More informationSepsis Management Update 2014
Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma
More informationSepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti
Sepsis and Hemodynamic Support in 2017 September 15, 2017 Carleen Risaliti Objectives Review fluid resuscitation guidelines in septic shock Discuss volume assessment v. fluid responsiveness Evaluate pros
More informationSepsis. From EMS to ER to ICU. What we need to be doing
Sepsis From EMS to ER to ICU What we need to be doing NEHAL BHATT, MD ATHENS PULMONARY, CRITICAL CARE AND SLEEP Objectives 1. Define the changes to the definition of Sepsis 2. Describe the assessment,
More informationControversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy
Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical
More informationSurviving Sepsis Campaign
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview By professor Ahmad Alaysh BMC-MICU 1 Surviving Sepsis A global program to Reduce mortality rates in severe
More informationPatient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014
Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Presenters Mark Blaney, RN Regional Nurse Educator CHI Franciscan Health Karen Lautermilch Director, Quality & Performance
More informationHow can the PiCCO improve protocolized care?
How can the PiCCO improve protocolized care? Azriel Perel Professor and Chairman Department of Anesthesiology and Intensive Care Sheba Medical Center, Tel Aviv University, Israel ESICM, Vienna 2009 Disclosure
More informationFluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS
Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available
More informationHow to resuscitate the patient in early sepsis? A physiological approach. J.G. van der Hoeven, Nijmegen
How to resuscitate the patient in early sepsis? A physiological approach J.G. van der Hoeven, Nijmegen Disclosure interests speaker (potential) conflict of interest Potentially relevant relationships with
More information4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures
Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare
More information4/4/2014. Of patients diagnosed with sepsis 50% will develop severe sepsis 25% will develop shock. SIRS Sepsis Severe Septic Sepsis Shock.
A summary of pathophysiology, therapeutics, and how the pharmacy TECHNICIAN can help improve OUTCOMES Anthony Nelson 2014 Pharm.D. Candidate Tricia Aggers, Pharm.D. Affiliate Faculty, ISU College of Pharmacy
More informationSepsis Management: Past, Present, and Future
Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe
More informationUPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center
UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center ShannonFry@fhshealth.org DISCLOSURE I have no financial relationships to disclose OBJECTIVES
More informationSurviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.
Surviving Sepsis Campaign Guidelines 2012 & Update for 2015 David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Louis Be appropriately aggressive the longer one delays aggressive metabolic
More informationSepsis: Update on Diagnosis, Evaluation and Management
Sepsis: Epidemiology Sepsis: Update on Diagnosis, Evaluation and Management Michael J. Apostolakos, MD Professor of Medicine Director of Adult Critical Care University of Rochester ~ 750,000 cases per
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More information6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,
Sepsis Management and Hemodynamics Javier Perez-Fernandez, M.D., F.C.C.P. Medical Director Critical Care Services, Baptist t Hospital of Miamii Medical Director Pulmonary Services, West Kendall Baptist
More informationSepsis: Identification and Management in an Acute Care Setting
Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES
More informationSEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson
SEPSIS 2015 William M. Johnson, MD Nebraska Pulmonary Specialties 1 DISCLOSURES William Johnson No financial interests related to this presentation 2 FINANCIAL DISCLOSURES I do however have 3 children
More informationF. BLOOS, K. REINHART Dep. of Anaesthesiology and Intensive Care Medicine, Klinikum der Friedrich-Schiller-Universität Jena, Jena, Germany
European Society of Anaesthesiologists Refresher Course MANAGEMENT OF SEPSIS 12 RC 5 F. BLOOS, K. REINHART Dep. of Anaesthesiology and Intensive Care Medicine, Klinikum der Friedrich-Schiller-Universität
More informationGoal-directed resuscitation in sepsis; a case-based approach
Goal-directed resuscitation in sepsis; a case-based approach Jorge A Guzman, MD, FCCM Head, Section Critical Care Medicine Respiratory Institute Cleveland Clinic Foundation The challenges to managing septic
More informationSepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018
Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018 Objectives 1. To identify the symptom of severe sepsis and septic shock syndrome.
More informationSeptic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
More informationOHSU. Update in Sepsis
Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin
More informationAcute Liver Failure: Supporting Other Organs
Acute Liver Failure: Supporting Other Organs Michael A. Gropper, MD, PhD Professor of Anesthesia and Physiology Director, Critical Care Medicine University of California San Francisco Acute Liver Failure
More informationUnderstand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the
Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the differences between sepsis, severe sepsis and septic
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationI n 2001, Rivers et published a landmark
828 REVIEW Early goal-directed therapy: a UK perspective A D Reuben, A V Appelboam, l Higginson, J G Lloyd, N I Shapiro... The surviving sepsis campaign developed guidelines in 2003 that were designed
More information6-horas 24 horas Coleta de lactato Hemoculturas. Corticosteróides. Controle glicêmico. Fluidos/vasopressores. Otimização de SvO 2
Novas diretrizes da Surviving Sepsis Campaign 2012 o que foi atualizado? Os pacotes da sepse 6-horas 24 horas Coleta de lactato Hemoculturas Corticosteróides Antibióticos Proteína C ativdada Fluidos/vasopressores
More informationThe syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa
The syndrome formerly known as Severe Sepsis James Rooks MD Coordinator of critical care education OU College of Medicine, Tulsa Disclosures I have no actual or practical conflicts of interest in relation
More informationManaging Patients with Sepsis
Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
More informationSepsis. Reliability- can we achieve Dr Ron Daniels
Sepsis. Reliability- can we achieve it? @SepsisUK Dr Ron Daniels Chief Executive, Global Sepsis Alliance Fellow: NHS Improvement Faculty Chief Executive: United Kingdom Sepsis Trust & Chair, UK SSC RRAILS
More informationTHE EFFECT OF DIFFERENT ENERGY AND PROTEINS LEVELS IN DIET ON PRODUCTION PARAMETERS OF BROILER CHICKEN FROM TWO GENOTYPES**
Biotechnology in Animal Husbandry 23 (5-6), p 551-557, 2007 ISSN 1450-9156 Publisher: Institute for Animal Husbandry, Belgrade-Zemun UDC 636.084.52 THE EFFECT OF DIFFERENT ENERGY AND PROTEINS LEVELS IN
More informationSurviving Sepsis: A CRASH Course. Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015
Surviving Sepsis: A CRASH Course Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015 Disclosures No financial conflicts of interest Abbreviations ULN Upper limit of normal SVCO2 Central
More informationDiagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire
Diagnosis and Management of Sepsis and Septic Shock Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire Financial: none Disclosures Objectives: Identify physiologic principles of septic
More informationUTILITY of ScvO 2 and LACTATE
UTILITY of ScvO 2 and LACTATE Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland THIS TRIP SPONSORED AND PAID FOR BY STRUCTURE Physiology -
More informationThe Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust
The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The
More informationVOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS
Department of Intensive Care Medicine VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS SEPTIC SHOCK : THE CLINICAL SCENARIO HYPOTENSION DESPITE ADEQUATE VOLUME RESUSCITATION
More informationtowards early goal directed therapy
Paediatric Septic Shock- towards early goal directed therapy Elliot Long Paediatric Acute Care 2011 Conference Outline Emergency Department Rivers Protocol (EGDT) ACCM Sepsis Protocol Evidence Barriers
More informationNothing to disclose 9/25/2017
Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain
More informationCORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE
CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE 1 ABBREVIATIONS ACCP = American College of Chest Physicians ARF =
More information9/25/2017. Nothing to disclose
Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain
More informationREZIDUALNA FUNKCIJA BUBREGA I KRVNA SLIKA BOLESNIKA NA KONTINUIRANOJ AMBULANTNOJ PERITONEUMSKOJ DIJALIZI
RADOVI BIBLID: 0370-8179, 134(2006) 11-12, p. 503-508 UDC: 616.61-008.6-78:616.15 REZIDUALNA FUNKCIJA BUBREGA I KRVNA SLIKA BOLESNIKA NA KONTINUIRANOJ AMBULANTNOJ PERITONEUMSKOJ DIJALIZI Nataša JOVANOVIĆ,
More informationGuidelines are the Future of Sepsis Management Pro
Guidelines are the Future of Sepsis Management Pro R. Phillip Dellinger MD, MCCM Professor and Chair of Medicine Director Adult Health Institute Senior Critical Care Attending Camden NJ USA Objectives
More informationPHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT
PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT Melanie Sanchez, RN, MSNE, OCN, CCRN Clinical Nurse III City of Hope National Medical Center HOW THE EXPERTS TREAT HEMATOLOGIC MALIGNANCIES LAS VEGAS, NV
More informationPerioperative and Early Postoperative Outcome of Proximal Femoral Nailing for Stable and Unstable Trochanteric Fractures
ACTA FACULTATIS MEDICAE NAISSENSIS DOI: 10.1515/afmnai-2016-0005 UDC: 616.718.4-001.5-089 Perioperative and Early Postoperative Outcome of Proximal Femoral Nailing for Stable and Unstable Trochanteric
More informationNo conflicts of interest to disclose
No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationVREDNOSTI C-REAKTIVNOG PROTEINA KOD NOVOROĐENČADI SA SEPSOM
RADOVI BIBLID: 37-879, 3(8) 5-, p. 53-57 DOI:.98/SARH853V UDC:.94-53.-78 VREDNOSTI C-REAKTIVNOG PROTEINA KOD NOVOROĐENČADI SA SEPSOM Brankica VASIQEVIĆ, Olga ANTONOVIĆ, Svjetlana MAGLAJLIĆ-ĐUKIĆ, Miroslava
More informationThe 2016 Surviving Sepsis Guidelines have arrived, a
A Users Guide to the 2016 Surviving Sepsis Guidelines R. Phillip Dellinger, MD, MCCM Christa A. Schorr, RN, MSN, FCCM Cooper University Health and Cooper Medical School of Rowan University Camden, NJ Mitchell
More informationEpidemiology of Severe Sepsis
Dellinger et al Crit Care Med 2008 Surviving Sepsis Phase I: the Barcelona Declaration Phase II: development and publication of guidelines 2004, updated in 2008 Phase III: operationalize the guidelines,
More informationDr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB
State of the Art Hemodynamic Monitoring III CO, preload, lung water and ScvO2 The winning combination! Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia
More informationManagement of Severe Sepsis:
Management of Severe Sepsis: Update from the Surviving Sepsis Campaign Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University NONE Disclosures Review evidence-based international sepsis
More informationVasopressors for shock
Vasopressors for shock Background Reviews and Observational Studies Holler 2015. Nontraumatic Hypotension and Shock in the Emergency Department and Prehospital Setting Prevalence, Etiology and Mortality:
More informationOtkazivanje rada bubrega
Kidney Failure Kidney failure is also called renal failure. With kidney failure, the kidneys cannot get rid of the body s extra fluid and waste. This can happen because of disease or damage from an injury.
More informationSurviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM
1 Surviving Sepsis Brian Woodcock MBChB MRCP FRCA FCCM 2 Disclosures No conflicts of interest 3 Sepsis Principles of management of septic shock in the operating room "Surviving Sepsis" guidelines 4 Add-on
More informationUpdates in Sepsis 2017
Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials
More informationUpdates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign
Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the
More informationSeptic shock. Babak Tamizi Far M.D Isfahan university of medical sciences
Septic shock Babak Tamizi Far M.D Isfahan university of medical sciences Definitions Used to Describe the Condition of Septic Patients Approximately 750,000 cases of severe sepsis or septic shock occur
More informationSURVIVING SEPSIS: Early Management Saves Lives
SURVIVING SEPSIS: Early Management Saves Lives Pat Posa RN, BSN, MSA System Performance Improvement Leader St. Joseph Mercy Health System Ann Arbor, MI Patricia.posa@stjoeshealth.org Objectives a. Understand
More informationSevere Sepsis/ Septic Shock. Fereshte Sheybani, MD. Assistant Professor in Infectious Diseases
Severe Sepsis/ Septic Shock Fereshte Sheybani, MD. Assistant Professor in Infectious Diseases Sepsis is one of the oldest and most elusive syndromes in medicine. Hippocrates claimed that sepsis (σήψις)
More informationUloga obiteljskog liječnika u prepoznavanju bolesnika s neuroendokrinim tumorom
Uloga obiteljskog liječnika u prepoznavanju bolesnika s neuroendokrinim tumorom Dr.sc. Davorin Pezerović OB Vinkovci 11.05.2017. For Za uporabu use by Novartisovim speakers predavačima and SAMO appropriate
More informationMortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project
Libby, MT Sepsis Quality Improvement Project Barb Dumont RN, Director of Quality and Risk Management Mike Julius RN, ED Manager Cathy Wolfe RN, Chief Nursing Officer. Mortality Rate was unsightly!!! percent
More informationUse of Blood Lactate Measurements in the Critical Care Setting
Use of Blood Lactate Measurements in the Critical Care Setting John G Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Labs Professor of Pathology Duke University Medical Center Chief, VAMC
More informationThe Hemodynamic Puzzle
The Hemodynamic Puzzle SVV NIRS O 2 ER Lactate Energy Metabolism (Oxygen Consumption) (Ml/min/m 2 ) Oxygen Debt: To Pay or Not to Pay? Full Recovery Possible Delayed Repayment of O 2 Debt Oxygen Deficit
More informationSubclinical Problems in the ICU:
Subclinical Problems in the ICU: Corticosteroid Insufficiency C. S. Cutillar, M.D., FPCP, FPSEM Associate Professor Cebu Institute of Medicine H-P-A Axis during Critical Illness CRH ACTH H-P-A Axis during
More informationBillion
Surviving : Are we? The 7th National Emergency Medicine Congress Antalya, Turkey Alexander L. Eastman, MD, MPH Department of Surgery UTSW Severe : A Significant Healthcare Challenge Major cause of morbidity
More informationImmunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC
Immunomodulation and Sepsis in Oncological Patients Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC 1 Objectives Immune dys-regulation in oncological septic patients Implementation
More informationGoal-directed vs Flow-guidedresponsive
Goal-directed vs Flow-guidedresponsive therapy S Magder Department of Critical Care, McGill University Health Centre Flow-directed vs goal directed strategy for management of hemodynamics S Magder Curr
More informationTITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management
TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management DATE: 01 June 2010 CONTEXT AND POLICY ISSUES: Sepsis syndrome covers a broad array
More information( 12 17mLO 2 /dl) 1.39 Hb S v O P v O2
32 1970 Harold James Swan William Ganz N Engl J Med 1) 40 (mixed venous oxygen saturation S v O2 ) (central venous oxygen saturation Scv O2 ) (Hb) S v O2 Scv O2 1971 Ganz 2) 20 Forrester Swan Forrester
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationEARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer
EARLY GOAL DIRECTED THERAPY : Etat des lieux en 2017 Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past-President European
More informationDESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS
DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS R. Phillip Dellinger MD, MSc, MCCM Professor and Chair of Medicine Cooper Medical School of Rowan University Chief of Medicine Cooper University Hospital
More informationSepsis and septic shock Practical hemodynamic consequences. Intensive Care Training Program Radboud University Medical Centre Nijmegen
Sepsis and septic shock Practical hemodynamic consequences Intensive Care Training Program Radboud University Medical Centre Nijmegen Septic cardiomyopathy Present in > 50% and often masked by low vascular
More informationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
More informationSepsis and septic shock: can we win the battle against this hidden crisis?
REVIEW ARTICLE Sepsis and septic shock: can we win the battle against this hidden crisis? V.G. Dassanayake Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka Key words : Sepsis;
More informationLooking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases
Sepsis: Update Prevalence of High Profile Dzs Edward A. Panacek, MD, MPH Professor and Chair, Emergency Medicine USA Medical Center, Mobile, AL NDAFP Conference Big Sky. 2016 Syllabus Angus Crit Care Med
More informationWhy does it matter? Sepsis
Sepsis 2015 Mitchell M. Levy MD, FCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School of Brown University Providence, RI Sepsis Why does it matter?
More informationShould Roids Be the Rage in Septic Shock? Lauren Powell, MSN, RN, CCRN, AGACNP-BC CHI Baylor St. Luke s Medical Center, Houston, TX
Should Roids Be the Rage in Septic Shock? Lauren Powell, MSN, RN, CCRN, AGACNP-BC CHI Baylor St. Luke s Medical Center, Houston, TX Learning Objectives 1. Review the mechanism of action for the use of
More informationInflammation. Sepsis Ladder
Maureen Maloney-Poldek MSN, RN Chamberlain College of Nursing Pathophysiology of sepsis and septic shock How sepsis affects the endocrine system Pathophysiology of adrenal insufficiency Clinical manifestations
More informationSepsis Awareness and Education
Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education
More informationSurviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
More informationSepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment
Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus
More informationImpact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department
Clin Exp Emerg Med 2014;1(1):35-40 http://dx.doi.org/10.15441/ceem.14.012 Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department
More informationWhere did it all begin?
EXPLORE Healthcare Summit Sepsis: Can We Finally Just Relax on the SOFA? Mark Keuchel, D.O. Background: 1. Sepsis is a wide-spectrum disease process that remains poorly understood 2. Early-goal directed
More informationIV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London
IV fluid administration in sepsis Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London The talk What is septic shock? What are the recommendations? What is the evidence? Do we follow
More informationEffect of Oral Hygiene Training on the Plaque Control in Patients Undergoing Treatment with Fixed Orthodontic Appliances
ORIGINAL ARTICLE / ORIGINALNI RAD Serbian Dental Journal, vol. 57, N o 1, 2010 7 UDC: 616.31-083:616.314-77 DOI: 10.2298/SGS1001007M Effect of Oral Hygiene Training on the Plaque Control in Patients Undergoing
More informationPediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee
Pediatric Septic Shock Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee Case 4 year old male with a history of gastroschesis repaired
More information